Acknowledgement

This activity is provided by Talem Health and RME Collaborative.
     
In collaboration with the Southeast AIDS Education & Training Center.

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

Credit Available

• Physicians — maximum of 0.25 AMA PRA Category 1 Credit™
• Nurses — 0.25 Contact Hour
• Pharmacists — 0.25 Contact Hour (0.025 CEU)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed specifically for primary care clinicians including physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other members of the multidisciplinary team (clinical and non-clinical) who serve patients from rural and underserved communities. 

Program Overview

Healthcare professionals play a pivotal role in creating inclusive, welcoming care environments that support the dignity, trust, and wellbeing of individuals living with HIV. However, they may unintentionally contribute to stigma through insensitive or inaccurate language, behaviors, or terminology, leading to patient discomfort and mistrust. This activity, which is part of a three-part series titled Walking in Their Shoes: First-Person Insights Into HIV Stigma, showcases the personal perspectives of Ashley, a Black woman with HIV who is having her blood drawn during a follow-up visit. The video highlights Ashley’s inner reflections as she navigates two contrasting clinical experiences—one marked by discomfort and stigma, and another characterized by respectful, supportive interactions. Expert faculty conclude by offering key insights on both scenarios, addressing common misconceptions about HIV transmission, and highlighting best practices for delivering patient-centered, compassionate care. 

The content for this enduring activity was recorded on April 5, 2025. 

Learning Objective

Upon completion of this activity, participants should be better able to: 

• Use evidence-based communication strategies for addressing HIV-related disparities, misconceptions, and stigma in rural and underserved settings  

Faculty

Onyema E. Ogbuagu, MBBCh, FACP, FIDSA
Associate Professor of Medicine
Director, Antivirals and Vaccines Research Program
Yale School of Medicine
Attending Physician, Infectious Diseases
Yale New Haven Health, Yale Medicine
New Haven, CT

Joint Accreditation Statement

In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

Physician Continuing Medical Education
Talem Health designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hour.

Continuing Pharmacy Education
Talem Health designates this continuing education activity for 0.25 contact hour (0.025 CEU) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008332-0000-25-023-H02-P)
Type of Activity: Knowledge

Disclosure of Conflicts of Interest

Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

All relevant financial relationships have been mitigated.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Faculty

Onyema E. Ogbuagu, MBBCh, FACP, FIDSA, has disclosed the following relevant financial relationships: consultant/advisory board member for Gilead Sciences, Inc. and ViiV Healthcare.

Planners, Managers, and Reviewer

The Talem Health planners, managers, and reviewer have nothing to disclose.

Instructions for Participation and Credit

This activity is offered at no cost to participants. To receive CME credit, participants must:

1. Read the CME/CE information, including learning objectives and disclosure statements.
2. Complete the pre-test.
3. View the online activity.
4. Complete the post-test and evaluation form.

A post-test score of 100% is required to obtain credit. Your certificate will be made available for immediate download.

Course Viewing Requirements

Supported Browsers:  
Desktop/laptop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge  
Mobile devices: Newest and last prior version of Safari and Google Chrome  

Supported Phones & Tablets:  
All devices  

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.

Media

Internet activity

Fee Information

There is no fee for this educational activity.

Contact Information

For questions about this activity, please contact RME Collaborative (a division of Talem Health) at 800-913-9370 or cme@cmeruralhealth.com.